NCT06244576

Brief Summary

This clinical trial employs a two-fold approach, utilizing a single-arm feasibility design within a larger multiple baseline experimental case series study framework over 32 weeks. The study aims to investigate both the feasibility and efficacy of Radically Open Dialectical Behaviour Therapy (RO-DBT) in patients with anorexia nervosa (AN). Feasibility will be assessed through treatment retention, data collection engagement, patient satisfaction, and the occurrence of adverse events. Efficacy outcomes will focus on RO-DBT's impact on ED psychopathology, obsessive-compulsive personality traits, EDR, and BMI.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

December 11, 2024

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

January 22, 2024

Last Update Submit

December 5, 2024

Conditions

Keywords

Anorexia nervosaInterventionMultiple baseline case-series experimental design studyPrimary outcome: EDE-Q total scoreRO DBTFeasibility

Outcome Measures

Primary Outcomes (1)

  • The Eating Disorder Examination Questionnaire (EDE-Q)

    A 36-item self-report questionnaire designed to measure eating disorder symptoms. The range of scores is 0-132. Higher scores mean more eating disorder symptoms

    32 weeks

Secondary Outcomes (4)

  • The Five Factor Obsessive Compulsive Inventory - Short Form (FFOCI-SF)

    32 weeks

  • The Emotion Regulation Questionnaire (ERQ)

    32 weeks

  • Body mass index (BMI)

    32 weeks

  • Client Satisfaction Questionnaire (CSQ-8)

    32 weeks

Study Arms (1)

Radically Open Dialectical Behaviour Therapy (RO-DBT)

EXPERIMENTAL

RO-DBT consists of a 1 hour weekly individual session and a 2,5 hour weekly group skill training during 32 weeks in accordance with the published treatment manual and session guides for RO-DBT. For skills training, the 31 patients will be divided into four equal groups in terms on number.

Behavioral: Radically Open Dialectical Behaviour Therapy (RO-DBT)

Interventions

RO-DBT is a trans diagnostic intervention specifically designed to treat a spectrum of disorders characterized by excessive overcontrol such as anorexia nervosa, autism spectrum disorder, refractory depression, cluster c personality disorders, and mood disorders.

Radically Open Dialectical Behaviour Therapy (RO-DBT)

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of anorexia nervosa or atypical nervosa (i.e., in partial remission with a BMI above \~18.5 but meets criteria B and/or C) according to the Diagnostic and Statistical Manual fifth edition (DSM-5)
  • Signed written informed consent form
  • Age 16-65
  • Sufficient knowledge of Swedish

You may not qualify if:

  • Substance dependence
  • Not willing to accept randomization
  • Undergoing simultaneous psychotherapy via another healthcare provider
  • Intellectual disability
  • Any psychiatric, medical or social condition whether or not listed above, due to which, in the judgment of the investigators and after any consults if indicated, participation in the study is not in the best interest of the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sundsvalls sjukhus, Lasarettsvagen 21

Sundsvall, Västernorrland County, 856 43, Sweden

Location

Related Links

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Magnus Sjögren, PhD

    Umea University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2024

First Posted

February 6, 2024

Study Start

September 15, 2023

Primary Completion

May 15, 2025

Study Completion

December 30, 2025

Last Updated

December 11, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations